The following is a summary of “Tumor-Infiltrating Lymphocyte Scoring Improves Progression Risk Prediction in Stage II Melanoma: A Retrospective Cohort Study,” published in the March 2025 issue of Journal of the American Academy of Dermatology by Adigbli et al. The AJCC 8th edition substaging was found to be limited in predicting melanoma progression, potentially leading […]
The post Non-Brisk TILs Indicate High Risk in Stage II Melanoma first appeared on Physician’s Weekly.
